Position in PFE
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$11,300,430
-$1,733,491 QoQ
Shares Held
469,287
+1.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
#390
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026THOMPSON INVESTMENT MANAGEMENT, INC. holds $48,347,417 across 11 Drug Manufacturers - General names. PFE ranks #2 (23.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
48,713 | $12,371,640 | |
| 2 | PFE |
Pfizer Inc
This page
|
469,287 | $11,300,430 | |
| 3 | ABBV |
AbbVie Inc.
|
34,736 | $8,740,967 | |
| 4 | AMGN |
Amgen Inc
|
18,002 | $6,518,884 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
105,721 | $6,091,644 | |
| 6 | MRK |
Merck & Co., Inc.
|
24,470 | $3,144,395 | |
| 7 | GSK |
GSK plc
|
1,680 | $88,065 | |
| 8 | AZN |
Astrazeneca PLC
|
324 | $61,436 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,300,430 | 469,287 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $13,033,921 | 464,171 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $11,540,029 | 463,455 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $10,908,752 | 428,130 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $10,083,743 | 415,996 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $10,410,812 | 410,845 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $10,703,899 | 403,464 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $11,034,387 | 381,285 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $10,518,465 | 375,928 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $10,218,243 | 368,225 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $10,236,975 | 355,574 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $4,955,598 | 149,400 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $5,288,632 | 144,183 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $5,410,324 | 132,606 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $3,492,825 | 68,166 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $2,982,944 | 68,166 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $3,755,770 | 71,634 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,765,439 | 72,734 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $4,320,334 | 73,164 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $4,373,643 | 101,689 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $3,995,651 | 102,034 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $3,386,925 | 93,484 | Shares | Sole | 2021-04-07 | |
| 2020-12-31 | $3,437,869 | 93,395 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $2,562,391 | 69,820 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $2,272,129 | 69,484 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $2,349,554 | 71,984 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||